Tech Company Financing Transactions
Novoron Bioscience Funding Round
On 1/6/2026, Novoron Bioscience secured $2.5 million in funding from National Institutes of Health.
Transaction Overview
Company Name
Announced On
1/6/2026
Transaction Type
Debt
Amount
$2,500,000
Round
Undisclosed
Investors
Proceeds Purpose
The award will support the development and commercialization of Novoron's human brain organoid platform.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1155 Island Avenue 100
San Diego, CA 92101
USA
San Diego, CA 92101
USA
Phone
Undisclosed
Website
Email Address
Overview
Our mission is to develop innovative therapies to restore independence and improve patient's lives. We meticulously explore every option to maximize benefits, such as multi-modality discovery and optimized drug delivery. We believe that while the "fail fast" model can avoid costly false positives, our responsibility to patients is to avoid false negatives to ensure that we deliver the best possible therapies and not be limited by the perception of "good enough".
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
David Weiner
Chief Executive Officer
Travis Stiles
Chief Financial Officer
Ryan McMillian
Chief Operating Officer
Shawn Gahr
Browse more venture capital transactions:
Prev: 1/6/2026: i10X venture capital transaction
Next: 1/7/2026: mBaaS venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs